RTRonise Tocheto

Ronise Tocheto

*This is an algorithmically generated author record based on publicly available information.

Ronise Tocheto has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Postoperative analgesic efficacy of pharmacopuncture at Zusanli (ST-36) or intramuscular morphine in bitches undergoing unilateral total mastectomy: a randomized clinical trial

    by G.J. Serighelli, F. A. Costa, D. Cavallini, F. Comassetto, R. Tocheto, R.P. Mendes, T.R. Müller, N. Oleskovicz

    This study aimed to compare the postoperative analgesic efficacy of intramuscular morphine and morphine pharmacopuncture at the Zusanli acupoint (ST-36) in female dogs undergoing unilateral total mastectomy. Sixteen client-owned bitches were randomly assigned to a double-blinded clinical trial and received either intramuscular morphine (0.5mg/kg; MORP) or pharmacopuncture with a microdose of morphine (0.05mg/kg) at ST-36 (ZUS36). Pain assessments were conducted at T0-T24 hours using the Visual Analog Scale (VAS) and the short-form Glasgow Composite Pain-Scale (CMPS-SF), evaluated by an experienced (EE) and a non-experienced assessor (NEE). Both protocols provided effective analgesia, with no significant differences in postoperative pain scores. The number of rescue interventions based on VAS assessments was 8 for MORP and 6 for ZUS36, while CMPS-SF evaluations recorded 15 and 13 interventions, respectively, for EE. The NEE overestimated rescue analgesia requirements in VAS assessments (11 rescues for MORP vs. 7 for ZUS36) but underestimated them in CMPS-SF evaluations (13 for MORP vs. 11 for ZUS36). A strong correlation was observed between EE and NEE in CMPS-SF (r=0.940) and VAS (r=0.748). Pharmacopuncture at ST-36 provided analgesia comparable to intramuscular morphine, highlighting its potential as an adjuvant analgesic strategy to reduce opioid requirements in canine mastectomy.

  • Open Access

    Maropitant in Cats Undergoing Ovariohysterectomy: Evaluation of Clinical and Analgesic Effects

    by Luana Marcia Rocha, Gilberto Serighelli Júnior, Ronise Tochetto, Luara Da Rosa, Felipe Comassetto, Nilson Oleskovicz

    Background: Emesis is a frequent adverse effect associated with the use of α2-adrenergic agonists and opioids in veterinary medicine, particularly in cats, where it’s incidence can reach up to 80%. Maropitant, a neurokinin-1 (NK1) receptor antagonist, has demonstrated potent antiemetic properties and potential analgesic effects, making it a promising candidate for perioperative management. However, its efficacy in modulating intraoperative and postoperative analgesia in cats undergoing ovariohysterectomy (OH) remains underexplored. Materials, Methods & Results: A double-blinded, randomized clinical trial was conducted with 16 healthy female cats divided into 2 groups. The maropitant group (MG) received 1 mg/kg subcutaneously 1 h prior to preanesthetic medication with dexmedetomidine (5 μg/kg) and morphine (0.3 mg/kg), while the control group (CG) received an equivalent volume of saline. Anesthesia was induced with propofol and maintained with isoflurane. Intraoperative parameters, including heart rate (HR), systolic arterial pressure (SAP), and fentanyl rescue requirements, were monitored. Postoperative analgesia was assessed using the UNESP/Botucatu multidimensional feline acute pain scale, with rescue analgesia administered as needed. Maropitant effectively prevented vomiting, with no instances of emesis observed in the MG, compared to a 62.5% incidence in the CG (P = 0.0256). HR and SAP increased during periods of heightened surgical stimulation in both groups, reflecting physiological responses to nociception; however, these increases were less pronounced in the MG, suggesting partial modulation of visceral pain. Intraoperative fentanyl rescues were significantly fewer in the MG (median: 9) compared to the CG (median: 13), particularly at moments of intense nociception (P = 0.0486). Postoperative pain scores showed no significant differences between groups, with both requiring similar numbers of rescue analgesia interventions during the evaluation period. Signs of nausea, such as sialorrhea and lip-licking, were observed in both groups, with no statistical differences, indicating that maropitant’s antinausea efficacy may be limited. Discussion: The findings highlight the dual role of maropitant as an antiemetic and adjunctive intraoperative analgesic. It’s complete inhibition of vomiting underscores it’s efficacy in blocking emetic signaling pathways via NK1 receptor antagonism in the brainstem vomiting center, particularly against stimuli from α2-adrenergic agonists and opioids. This antiemetic effect is clinically significant, improving the welfare of cats undergoing OSH by eliminating a common and distressing adverse effect. Furthermore, the reduction in intraoperative fentanyl rescues suggests that maropitant’s modulation of visceral nociception is effective, potentially linked to its ability to inhibit substance P-mediated nociceptive transmission in visceral afferents. However, the lack of significant differences in postoperative pain scores and analgesic rescues between groups suggests that maropitant’s analgesic efficacy may be dose-dependent or limited to the intraoperative period. In conclusion, Maropitant at a dose of 1 mg/kg administered subcutaneously is a valuable addition to perioperative protocols in cats undergoing OSH, effectively preventing vomiting and reducing intraoperative analgesic requirements. Further research is warranted to optimize dosing strategies and explore its integration within multimodal analgesic protocols to enhance its clinical applications. Keywords: maropitant, cats, emesis, pain.

  • Open Access

    Evaluation of tumescent local anesthesia, epidural technique, and dexmedetomidine infusion in bitches undergoing mastectomies: A randomized study of perioperative and postoperative analgesia

    by A.F.B.A. Costa, G.J. Serighelli, R. Tocheto, G.B. Conterno, L.B. Griebeler, F. Comassetto, N. Oleskovicz

    Total unilateral mastectomy is the standard technique for treating mammary tumors in dogs. Combined with multimodal analgesia, different anesthetic techniques improve pain control. This study evaluated the transoperative and postoperative analgesic efficacy of continuous dexmedetomidine infusion (GD), tumescence (GT), and epidural block (GE) using the Short Form of the Glasgow Composite Measure Pain Scale (CMPS-SF) in dogs undergoing mastectomy. Eighteen dogs were randomly assigned to three groups of six animals each. Vital parameters, including heart rate (HR), oxygen saturation (SpO2), systolic (SBP), diastolic (DAP), and mean arterial pressures (MAP), expired carbon dioxide fraction (FeCO2), expired isoflurane fraction (FeISO), and body temperature (T°C), were recorded. GD demonstrated a reduction in HR. FeISO requirements decreased by 25.6%, 8.12%, and 7.27% in GD, GT, and GE, respectively. GE required the highest number of intraoperative rescue interventions (10), followed by GD (5) and GT (4). Postoperatively, GD necessitated the most rescue interventions (10), followed by GE (7) and GT (3). GT provided superior postoperative analgesia, lasting up to 8 hours, while the other groups required rescue within the first hour of postoperative assessment. In conclusion, the tumescence technique offered more effective perioperative pain control, with prolonged postoperative analgesia.

  • Surgeon experience affects perioperative pain in cats undergoing elective ovariohysterectomy: a randomized clinical trial

    by Lorenzo S. B. Cavagnari, Vanessa S. Padilha, Ronise Tocheto, Bruna D. C. Regalin, Helena M. C. Pissetti, Felipe Comassetto, Nilson Oleskovicz

    OBJECTIVE: This study aimed to compare the outcomes between surgeries performed by either experienced or inexperienced surgeons by assessing intraoperative nociception and perioperative analgesia. METHODS: 16 healthy, client-owned female cats were randomly allocated into 2 groups of 8: one undergoing surgery by an experienced surgeon (GES group) and the other by inexperienced surgeons (GIS group). Both groups received IM premedication with acepromazine (0.05 mg/kg) and methadone (0.3 mg/kg). After 20 minutes, venipuncture and induction with propofol (dose-response, IV) were performed. Maintenance was achieved with inhaled isoflurane. Intraoperative vital parameters were monitored, and fentanyl (2.5 µg/kg, IV) was administered as rescue analgesia when needed. Postoperatively, pain was assessed with a visual analog scale and the multidimensional pain scale of the Universidade Estadual Paulista in Botucatu; morphine (0.2 mg/kg, IM) was used for rescue analgesia, as necessary. RESULTS: In the GIS group, significant increases in heart rate and systolic blood pressure were noted during surgery, especially during pedicle clamping. Respiratory rate and end-tidal isoflurane levels were higher in the GIS group at specific surgical stages. Survival analysis indicated that the GIS group had a greater need for fentanyl. Postoperative pain scores were generally low, but a higher proportion of GIS cats required rescue analgesia. CONCLUSIONS: Surgeon experience influences intraoperative parameters and fentanyl consumption. Inexperienced surgeons contribute to increased postoperative pain and poorer wound healing outcomes in cats undergoing elective ovariohysterectomy. CLINICAL RELEVANCE: Ovariohysterectomy is a common procedure in veterinary practice, and surgical expertise significantly impacts pain management and recovery. Yet, its effects have been underexplored, potentially compromising animal welfare.


  • Open Access

    Comparison of cardiorespiratory effects and perioperative analgesia efficacy of dexmedetomidine or fentanyl continuous infusion during ovariohysterectomy in propofol-anesthetized dogs

    by Gabriela Conterno, Felipe Comassetto, Murilo Gabriel Consolim, Ronise Tocheto, Nilson Oleskovicz

    The present study aimed to compare the cardiorespiratory, perioperative analgesic and blood gas analysis of the constant rate infusion of dexmedetomidine or fentanyl in 16 female dogs undergoing to elective ovariohysterectomy. The dogs were premedicated with morphine (0.5 mg/kg) and dexmedetomidine (5 µg/kg) or acepromazine (0.05 mg/kg), both intramuscularly (IM), in GDEX or GFEN, respectively. After anesthesia induction with propofol intravenously (IV), animals of GFEN received bolus of fentanyl (2.5 µg/kg) IV followed by continuous rate infusion (CRI) (10 µg/kg/h) and the GDEX received bolus of saline solution 0.9% (corresponding volume of fentanyl) followed by CRI of dexmedetomidine (1 µg/kg/h) and anesthesia was maintained with propofol (0.22 mg/kg/min). In the end of surgery all animals were evaluated using the Glasgow composite measure pain scale (GCPS) and a visual analogue scale (VAS). Data was compared with a statistical p value > 0,05. The mean heart rate was statistically lower in GDEX when compared to GFEN (p = 0.0498): 54.25 ± 3.919 and 88.38 ± 8.766 beats per minute, respectively. Opposed, the average mean blood pressure was statistically higher in GDEX when compared to GFEN (p = 0.0021): 99.38 ± 8.551 and 80.75 ± 11.12 mmHg, respectively. The GDEX and GFEN, in the firsts 4 and 2 postoperative hours, respectively, presented values significantly higher than baseline in the GCPS, occurring analgesic rescues for both groups. It is concluded that both drugs in the proposed rates were safe and efficient for nociceptive control during intraoperative, however, failed to promote efficient postoperative analgesia.